查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| DX Dynex Capital Inc. Common Stock | 1.41 2026-12-31 | 1.39 – 1.42 | 4 | +3.49% | +2.55% | +7.16% | 0 / 0 | $389.91M |
| BDX Becton Dickinson and Company Common Stock | 12.56 2026-09-30 | 12 – 12.65 | 14 | +0.02% | +0.18% | +0.67% | 1 / 0 | $19.21B |
| DXCM DexCom Inc. Common Stock | 2.59 2026-12-31 | 2.45 – 2.65 | 25 | -0.02% | +0.05% | +3.74% | 6 / 2 | $5.22B |
| IDXX IDEXX Laboratories Inc. Common Stock | 14.62 2026-12-31 | 14.29 – 14.82 | 14 | 0.00% | -0.01% | +0.75% | 9 / 1 | $4.71B |
| DXC DXC Technology Company Common Stock | 2.56 2027-03-31 | 2.4 – 2.78 | 8 | -0.19% | -0.19% | -21.71% | 0 / 2 | $12.15B |
| FDXF FedEx Freight Holding Company Inc. Common Stock | 4.25 2026-05-31 | 4.18 – 4.31 | 5 | -1.16% | -1.27% | — | 0 / 0 | $8.92B |
| FDX FedEx Corporation Common Stock | 17.92 2026-12-31 | 17.4 – 20.24 | 10 | -0.20% | -2.35% | — | 0 / 0 | $90.93B |
| TMDX TransMedics Group Inc. Common Stock | 1.81 2026-12-31 | 1.6 – 2.32 | 10 | +2.35% | -10.30% | -26.18% | 0 / 3 | $733.18M |
| ALDX Aldeyra Therapeutics Inc. Common Stock | -0.3 2026-12-31 | -0.43 – -0.22 | 4 | — | — | — | 3 / 0 | $1.25M |
| ARDX Ardelyx Inc. Common Stock | -0.05 2026-12-31 | -0.16 – 0.02 | 7 | — | — | — | 0 / 0 | $541.51M |
| CLDX Celldex Therapeutics Inc. | -4.35 2026-12-31 | -4.57 – -3.95 | 11 | — | — | — | 6 / 0 | $2.42M |
| MDXG MiMedx Group Inc Common Stock | -0.07 2026-12-31 | -0.09 – -0.03 | 3 | — | — | — | 0 / 2 | $269.6M |
| SNDX Syndax Pharmaceuticals Inc. Common Stock | -1.6 2026-12-31 | -2.2 – -1.16 | 11 | — | — | — | 1 / 1 | $344.78M |
| WGS GeneDx Holdings Corp. Class A Common Stock | -0.06 2026-12-31 | -0.69 – 0.09 | 8 | — | — | — | 0 / 2 | $478.38M |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。